A Phase 3, Randomized, Double Blind, Placebo-Controlled Study to Assess the Safety, Efficacy and Pharmacokinetics of Natroba™ (Spinosad) for the Treatment of Scabies
Phase of Trial: Phase III
Latest Information Update: 04 Dec 2017
At a glance
- Drugs Spinosad (Primary)
- Indications Scabies
- Focus Registrational; Therapeutic Use
- Sponsors ParaPRO
- 28 Nov 2017 Planned primary completion date changed from 1 Jan 2018 to 15 Mar 2018.
- 02 May 2017 Status changed from not yet recruiting to recruiting.
- 13 Mar 2017 Planned number of patients changed from 75 to 120.